Scientists have uncovered a hidden “death switch” in the brain that may be driving Alzheimer’s disease—and even found a way ...

How to watch the Michigan State vs. Louisville second-round game today in the men's NCAA basketball tournament March Madness ...

The results of the EVOKE and EVOKE+ trials were comprehensive in showing oral semaglutide’s lack of clinical efficacy for ...

Science rarely hands us plot twists this dramatic—where two of the most feared diseases of our time, cancer and Alzheimer’s, ...

A new study suggests that two of Alzheimer’s disease’s most debated players may be more closely connected than they first ...

NeuroCare Community Project’ will offer free screening to 6,000 underprivileged elderly residents over five years.

Oral semaglutide (a GLP-1 pill) is not effective at slowing progression in patients with mild Alzheimer's disease, finds the ...

Scientists may have sniffed out a breakthrough when detecting Alzheimer’s. The degenerative disease, which affects millions of Americans and gradually destroys memory, thinking skills and the capacity ...

Could a simple blood test predict your risk of getting dementia years, or even decades, before you experience memory loss? That’s the potential promise of a new class of biomark ...

Two large phase 3 trials found that oral semaglutide 14 mg did not slow cognitive or functional decline over 104 weeks in ...

At AD/PD 2026, one message stood out: when researchers share ideas across Alzheimer’s and Parkinson’s, it could help speed up progress towards better tests, new treatments and a deeper understanding ...

Amyloid beta and tau proteins compete for the same binding sites on microtubules in neurons, suggesting that displacement of ...